Targeting RyR2 with a phosphorylation site–specific nanobody reverses dysfunction of failing cardiomyocytes in rats-Reference-Cited by-同舟云学术

Targeting RyR2 with a phosphorylation site–specific nanobody reverses dysfunction of failing cardiomyocytes in rats

Published:2019-03-18 Issue:6 Volume:33 Page:7467-7478
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Li Tian¹²,Shen Yafeng¹,Lin Fangxing¹,Fu Wenyan³,Liu Shuowu²,Wang Chuqi²,Liang Jizhou²,Fan Xiaoyan¹,Ye Xuting¹,Tang Ying¹,Ding Min⁴,Yang Yongji¹,Lei Changhai¹²,Hu Shi¹²

Affiliation:

1. Department of BiophysicsCollege of Basic Medical SciencesSecond Military Medical UniversityShanghaiChina

2. Department of BiophysicsTeam SMMU-China of International Genetically Engineered Machine (iGEM) CompetitionsSecond Military Medical UniversityShanghaiChina

3. Department of Obstetrics and GynecologyShanghai First Maternity and Infant HospitalTongji University School of MedicineShanghaiChina

4. Pharchoice Therapeutics IncorporatedShanghaiChina

Funder

National Natural Science Foundation of China

Second Military Medical University

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802354R